Opko Sees Huge Long-Term Impact From Prolor Deal

Aug. 21 (Bloomberg) -- Phillip Frost, chief executive officer of Opko Health Inc., talks about its share listing on the Tel Aviv Stock Exchange today and the acquisition of Israeli drugmaker Prolor Biotech Inc. He speaks with Elliott Gotkine on Bloomberg Television's "On the Move." (Source: Bloomberg)
Mila Kunis Helps Miner Become Top Emerald Producer
20:35 - Gemfields CEO Ian Harebottle discusses the gemstone business with Bloomberg's Pimm Fox on "Taking Stock." (Source: Bloomberg)
  • Redfin CEO: How Apple Watch Will Change My Business
  • Is OrangeTheory the Next Big Thing in Fitness Data?
  • Behind the Documentary 'All Eyes and Ears'